Halozyme Therapeutics, Inc. (HALO)
70.69
-0.29
(-0.41%)
USD |
NASDAQ |
Feb 23, 13:48
Halozyme Therapeutics Price : 70.69 for Feb. 23, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 245.40 |
| Merck & Co., Inc. | 123.69 |
| Skye Bioscience, Inc. | 0.8174 |
| AIM ImmunoTech, Inc. | 1.03 |
| Stryker Corp. | 383.89 |
Price Related Metrics
| PE Ratio | 28.37 |
| PS Ratio | 6.211 |
| Price to Book Value | 170.30 |
| Price to Free Cash Flow | 13.46 |
| Earnings Yield | 3.53% |
| Market Cap | 8.313B |
| Operating PE Ratio | 10.63 |
| Normalized PE Ratio | 15.40 |